a history of prolonged diphenylhydantoin ( dilantin ) therapy was reported by 8 of 516 patients ( 1.6 % ) with hodgkin 's disease or non-hodgkin 's lymphoma , as compared with 3 of 516 patients ( 0.6 % ) with other cancers , and 2 of 516 ( 0.4 % ) tumor-free individuals .
C0006826
cancers
C0027651
tumor